|
gptkbp:instanceOf
|
inhalational anesthetic
halogenated ether
|
|
gptkbp:aroma
|
mild, sweet
|
|
gptkbp:ATCCode
|
N01AB02
|
|
gptkbp:boilingPoint
|
56.5 °C
|
|
gptkbp:CASNumber
|
13838-16-9
|
|
gptkbp:chemicalFormula
|
C3H2ClF5O
|
|
gptkbp:color
|
colorless
|
|
gptkbp:contraindication
|
epilepsy
malignant hyperthermia
|
|
gptkbp:density
|
1.52 g/cm³
|
|
gptkbp:discoveredBy
|
Ross C. Terrell
|
|
gptkbp:excretion
|
gptkb:kidney
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
enflurane
|
|
gptkbp:introducedIn
|
1963
|
|
gptkbp:IUPACName
|
2-chloro-1,1,2-trifluoroethyl difluoromethyl ether
|
|
gptkbp:KEGGID
|
D00219
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:marketedAs
|
gptkb:Abbott_Laboratories
|
|
gptkbp:meltingPoint
|
-44.5 °C
|
|
gptkbp:MeSH_ID
|
D004727
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:minimumAlveolarConcentration
|
1.68% (in adults)
|
|
gptkbp:molecularWeight
|
184.5 g/mol
|
|
gptkbp:PubChem_CID
|
3195
CHEMBL1200712
DB00228
|
|
gptkbp:relatedTo
|
gptkb:desflurane
gptkb:isoflurane
sevoflurane
halothane
|
|
gptkbp:riskFactor
|
gptkb:arrhythmia
hepatotoxicity
nephrotoxicity
increased intracranial pressure
uterine relaxation
|
|
gptkbp:routeOfAdministration
|
inhalation
|
|
gptkbp:sideEffect
|
muscle relaxation
seizures
hypotension
respiratory depression
|
|
gptkbp:solubility
|
slightly soluble
|
|
gptkbp:UNII
|
39L1Q1A3RD
|
|
gptkbp:usedFor
|
general anesthesia
|
|
gptkbp:vaporPressure
|
175 mmHg (at 20 °C)
|
|
gptkbp:withdrawn
|
gptkb:Canada
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:bfsParent
|
gptkb:Norflurane
gptkb:Desflurane
|
|
gptkbp:bfsLayer
|
8
|